Systemically Administered Sindbis Virus in Combination with Immune Checkpoint Blockade Induces Curative Anti-tumor Immunity

Oncolytic viruses represent a promising form of cancer immunotherapy. We investigated the potential of Sindbis virus (SV) for the treatment of solid tumors expressing the human cancer testis antigen NYESO-1. NYESO-1 is an immunogenic antigen frequently expressed in numerous cancers, such as ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherwitzl, Iris, Hurtado, Alicia, Pierce, Carolyn M., Vogt, Sandra, Pampeno, Christine, Meruelo, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026467/
https://www.ncbi.nlm.nih.gov/pubmed/29988525
http://dx.doi.org/10.1016/j.omto.2018.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026467/
https://www.ncbi.nlm.nih.gov/pubmed/29988525
http://dx.doi.org/10.1016/j.omto.2018.04.004

Ejemplares similares